Biotech in Belgium: news and updates

News and Trends 2 Apr 2020

iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding

An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which will be used to advance the clinical development of its two lead cancer immunotherapies. The…

April 2, 2020 - 3 minutesmins - By Laura Cowen

Startup Scout 13 Mar 2020

This Startup Hits Hidden Proteins to Make Cancer Immunotherapies

With one foot in Belgium and another in the US, Orionis Biosciences combines US and European talent to develop cancer immunotherapies targeting difficult protein targets. Mission: To fight cancer with…

March 13, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 19 Feb 2020

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment…

February 19, 2020 - 2 minutesmins - By Jonathan Smith

pdcLine Pharma dendritic cell cancer vaccine

News and Trends 22 Jan 2020

Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost

The French-Belgian company PDC*Line Pharma has raised a €20M Series B round to fund an ongoing phase I/II trial of its off-the-shelf therapeutic vaccine for lung cancer. The total €20M…

January 22, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Dec 2019

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M with the addition of new investors, including Innovation Growth Ventures and Pegasus Tech Ventures among…

December 17, 2019 - 2 minutesmins - By Jonathan Smith

imcyse type 1 diabetes insulin immunotherapy

News and Trends 28 Aug 2019

Type 1 Diabetes Immunotherapy Shows Promise in Phase I

An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown signs of clinical benefits and no major safety issues in a phase I trial. The…

August 28, 2019 - 3 minutesmins - By Jonathan Smith

agrosavfe belgium strawberry pesticide fungal

News and Trends 30 Jul 2019

Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides

The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired by llama antibodies. AgroSavfe will use the funds to develop…

July 30, 2019 - 2 minutesmins - By Jonathan Smith

anthrax treatment belgium VIB nanobodies

More News! 17 Jul 2019

Scientists in Belgium Cure Anthrax in Mice by Smashing Bacteria’s Armor

Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick protein armor. Anthrax is a deadly type of bacteria famous for its use in terrorist…

July 17, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Jun 2019

Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure

The Belgian company Imcyse has raised €35M in a Series B round to develop a potential cure for chronic autoimmune conditions including type 1 diabetes and multiple sclerosis. Imcyse will…

June 18, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Confo Therapeutics has raised €30M in a Series A round that will take its unique technology to find drugs for historically undruggable targets to clinical trials. The fundraising was…

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

crispr cas9 cassava crop virus resistance

News and Trends 29 Apr 2019

Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants

Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the bacterial weapon CRISPR-Cas9, which could have major regulatory implications. Geminiviruses are pathogens that kill off…

April 29, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 8 Apr 2019

AACR 2019: European Biotech Progresses in Fighting Cancer

The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the newest advances in cancer treatment from around the world. Sit back as we give you…

April 8, 2019 - 4 minutesmins - By Jonathan Smith

llama leo pharma argen x skin milestone inflammatory

More News! 3 Apr 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian…

April 3, 2019 - 2 minutesmins - By Jonathan Smith

Galapagos Gilead filgotinib rheumatoid arthritis

News and Trends 29 Mar 2019

Galapagos Nears First Drug Approval with Phase III Success in Rheumatoid Arthritis

Galapagos has released positive data from two phase III trials testing its flagship drug candidate, filgotinib, that will let the company and its partner Gilead apply for marketing approval. 20…

March 29, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

arthritis pediatric juvenile idiopathic Leuven

News and Trends 13 Mar 2019

Artificial Intelligence Detects Juvenile Arthritis in the Blood

Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with almost 90% accuracy and identify different forms of the disease, something that is not currently…

March 13, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Nov 2018

CAR-T Promise for Patients with Solid Tumors

A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results against solid tumors in two Phase I trials, including one trial that did not include add-on…

November 14, 2018 - 3 minutesmins - By Jonathan Smith

bone therapeutics bone disease hip header

News and Trends 7 Nov 2018

Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease

Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little hope of success for patients with the bone disease osteonecrosis. If all had gone as…

November 7, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Oct 2018

Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR

Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement with ERS Genomics, which licenses out CRISPR intellectual property in the EU. CRISPR technology is…

October 17, 2018 - 2 minutesmins - By Jonathan Smith

Interview 16 Oct 2018

Using the Skin Microbiome to Treat Acne

The microbes living on our skin can play an important role in skin conditions such as acne. Philip talked to Veronika Oudova, CEO and co-founder of the Belgian company S-Biomedic,…

October 16, 2018 - 4 minutesmins - By Jonathan Smith

Startup Scout 12 Oct 2018

This Biotech is the First to Work on Antivirals for Farm Livestock

While in Leuven, Belgium, for last week’s Biotech of the Week, we decided to go to the vet. ViroVet is a company aiming to improve viral disease control in livestock,…

October 12, 2018 - 3 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering